|
Concentration (sperm/mL)
|
CON
|
141.3 (65.5)
|
0.13 (0.11)
|
0
|
0
|
|
Viability 5 min
|
VIAB_5
|
90.1 (6.3)
|
1 × 10–6 (0.11)
|
0
|
0
|
|
Viability 90 min
|
VIAB_90
|
77.4 (17.3)
|
0.14 (0.13)
|
0
|
0
|
|
Osmotic resistance test
|
ORT
|
79.8 (12.5)
|
0.13 (0.12)
|
0
|
0
|
|
Head abnormalities
|
HABN
|
2.1 (5.9)
|
0.16 (0.11)
|
41
|
0
|
|
Neck abnormalities
|
NABN
|
3.0 (4.9)
|
1 × 10–6 (0.13)
|
18
|
0
|
|
Tail abnormalities
|
TABN
|
2.7 (3.4)
|
0.09 (0.12)
|
0
|
0
|
|
Proximal droplets
|
PDROP
|
3.5 (5.1)
|
0.12 (0.15)
|
1
|
0
|
|
Distal droplets
|
DDROP
|
4.5 (4.5)
|
0.06 (0.11)
|
0
|
0
|
|
Motility 5 min
|
MT_5
|
75.4 (18.1)
|
0.21 (0.15)
|
3
|
217
|
|
Motility 90 min
|
MT_90
|
64.1 (22.0)
|
0.39 (0.14)
|
2
|
252
|
|
Average path velocity 5 min (µm/seg)
|
VAP_5
|
34.0 (10.2)
|
0.17 (0.11)
|
0
|
0
|
|
Average path velocity 90 min (µm/seg)
|
VAP_90
|
30.8 (9.5)
|
0.35 (0.13)
|
0
|
0
|
|
Curvilinear velocity 5 min (µm/seg)
|
VCL_5
|
46.2 (12.5)
|
0.11 (0.10)
|
0
|
0
|
|
Curvilinear velocity 90 min (µm/seg)
|
VCL_90
|
39.7 (10.2)
|
0.35 (0.13)
|
0
|
0
|
|
Straight line velocity 5 min (µm/seg)
|
VSL_5
|
27.0 (8.3)
|
0.23 (0.13)
|
0
|
38
|
|
Straight line Velocity 90 min (µm/seg)
|
VSL_90
|
25.9 (8.3)
|
0.34 (0.13)
|
0
|
0
|
|
Abnormal acrosomes 5 min
|
ACRO_5
|
7.0 (5.6)
|
0.08 (0.11)
|
4
|
0
|
|
Abnormal acrosomes 90 min
|
ACRO_90
|
16.4 (12.6)
|
0.06 (0.10)
|
0
|
0
|
|
Ratio motility
|
R_MT
|
0.9 (0.2)
|
1 × 10–6 (0.11)
|
0
|
0
|
|
Ratio average path velocity
|
R_VAP
|
0.9 (0.3)
|
1 × 10–6 (0.08)
|
0
|
0
|
|
Ratio Curvilinear velocity
|
R_VCL
|
0.9 (0.3)
|
1 × 10–6 (0.09)
|
0
|
0
|
|
Ratio straight line velocity
|
R_VSL
|
1.0 (0.3)
|
0.06 (0.10)
|
0
|
0
|
|
Ratio viability
|
R_VIAB
|
0.9 (0.3)
|
0.08 (0.11)
|
0
|
0
|
|
Ratio acrosomes
|
R_ACRO
|
3.4 (3.5)
|
0.08 (0.11)
|
1
|
0
|
